The importance of analytical quality specifications for biomarker assays currently used in acute cardiac care

References

• Panteghini M. Performance of today's cardiac troponin assays and tomorrow's. Clin Chem 2002; 48: 809–10
   PubMed Web of Science ®Google Scholar
• Panteghini M., Gerhardt W., Apple F. S., Dati F., Ravkilde J., Wu A. H. Quality specifications for cardiac troponin assays. International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). Clin Chem Lab Med 2001; 39: 174–8
   Google Scholar
• Apple F. S., Panteghini M., Ravkilde J., Mair J., Wu A. H. B., et al. Quality specification for B‐type natriuretic peptide assays. Clin Chem 2005; 51: 486–93
   PubMed Web of Science ®Google Scholar
• Katrukha A., Bereznikova A., Pettersson K. New approach to standardization of human cardiac troponin I (cTnI). Scand J Clin Lab Invest 1999; 59((suppl 230))124–7
   Google Scholar
• Panteghini M., Forest J. C. Standardization in laboratory medicine: new challenges. Clin Chim Acta 2005; 355: 1–12
   PubMed Web of Science ®Google Scholar
• Panteghini M. Standardization of cardiac troponin I measurements: the way forward?. Clin Chem 2005; 51: 1594–7
   PubMed Web of Science ®Google Scholar
• Shi Q., Ling M., Zhang X., Zhang M., Kadijevic L., Liu S., et al. Degradation of cardiac troponin I in serum complicates comparisons of cardiac troponin I assays. Clin Chem 1999; 45: 1018–25
   PubMed Web of Science ®Google Scholar
• McDonough J. L., Arrell D. K., Van Eyk J. E. Troponin I degradation and covalent complex formation accompanies myocardial ischemia/reperfusion injury. Circ Res 1999; 84: 9–20
   PubMed Web of Science ®Google Scholar
• Panteghini M. Selection of antibodies and epitopes for cardiac troponin immunoassays: should we revise our evidence‐based beliefs?. Clin Chem 2005; 51: 803–4
   PubMed Web of Science ®Google Scholar
• Eriksson S., Halenius H., Pulkki K., Hellman J., Pettersson K. Negative interference in cardiac troponin I immunoassays by circulating troponin autoantibodies. Clin Chem 2005; 51: 839–47
   PubMed Web of Science ®Google Scholar
• Shimizu H., Masuta K., Asada H., Sugita K., Sairenji T. Characterization of molecular forms of probrain natriuretic peptide in human plasma. Clin Chim Acta 2003; 334: 233–9
   PubMed Web of Science ®Google Scholar
• Brandt I., Lambeir A. M., Ketelslegers J. M., Vanderheyden M., Scharpé S., De Meester I. Dipeptidyl‐peptidase IV converts intact B‐type natriuretic peptide into its des‐SerPro form. Clin Chem 2006; 52: 82–7
   PubMed Web of Science ®Google Scholar
• Ala‐Kopsala M., Magga J., Peuhkurinen K., Leipala J., Ruskoaho H., et al. Molecular heterogeneity has a major impact on the measurement of circulating N‐terminal fragments of A‐ and B‐ type natriuretic peptides. Clin Chem 2004; 50: 1576–88
   PubMed Web of Science ®Google Scholar
• Storti S., Prontera C., Emdin M., Passino C., Prati P., et al. Analytical performance and clinical results of a fully automated MEIA system for BNP assay: comparison with a POCT method. Clin Chem Lab Med 2004; 42: 1178–85
   PubMed Web of Science ®Google Scholar
• Clerico A., Prontera C., Emdin M., Passino C., Storti S., et al. Analytical performance and diagnostic accuracy of immunometric assays for the measurement of plasma B‐type natriuretic peptide (BNP) and N‐terminal proBNP. Clin Chem 2005; 51: 445–7
   PubMed Web of Science ®Google Scholar
• Emdin M., Clerico A., Clemenza F., Galvani M., Latini R., et al. Recommendations for the clinical use of cardiac natriuretic peptides. Ital Heart J 2005; 6: 430–46
   PubMedGoogle Scholar
• Ferguson J. L., Beckett G. J., Stoddart M., Walker S. W., Fox K. A. A. Myocardial infarction redefined: the new ACC/ESC definition, based on cardiac troponin, increases the apparent incidence of infarction. Heart 2002; 88: 343–7
   PubMed Web of Science ®Google Scholar
• Venge P., Lagerqvist B., Diderholm E., Lindahl B., Wallentin L. Clinical performance of three cardiac troponin assays in patients with unstable coronary artery disease (a FRISC II substudy). Am J Cardiol 2002; 89: 1035–41
   PubMed Web of Science ®Google Scholar
• Panteghini M., Pagani F., Yeo K. T. J., Apple F. S., Christenson R. H., et al. Evaluation of imprecision for cardiac troponin assays at low‐range concentrations. Clin Chem 2004; 50: 327–32
   PubMed Web of Science ®Google Scholar
• Sheehan P., Blennerhassett J., Vasikaran S. D. Decision limit for troponin I and assay performance. Ann Clin Biochem 2002; 39: 213–6
   Web of Science ®Google Scholar
• Panteghini M., Clerico A. Cardiac natriuretic hormones as markers of cardiovascular disease: methodological aspects. Natriuretic peptides. The hormones of the heart, A Clerico, M Emdin. Springer, HeidelbergGermany 2006; 65–89
   Google Scholar
• Banerjee S., Linder M. W., Singer I. False‐positive troponin I in a patient with acute cholecystitis and positive rheumatoid factor assay. Cardiology 2001; 95: 170–1
   PubMed Web of Science ®Google Scholar
• Collinson P. O., Barnes S. C., Gaze D. C., Galasko G., Lahiri A., Senior R. Analytical performance of the N terminal pro B type natriuretic peptide (NT‐proBNP) assay on the Elecsys 1010 and 2010 analysers. Eur J Heart Fail 2004; 6: 365–8
   PubMed Web of Science ®Google Scholar
• Panteghini M. The measurement of cardiac markers. Where should we focus?. Am J Clin Pathol 2002; 118: 354–61
   PubMed Web of Science ®Google Scholar
• Shimizu H., Aono K., Masuta K., Asada H., Misaki A., Teraoka H. Degradation of human brain natriuretic peptide (BNP) by contact activation of blood coagulation system. Clin Chim Acta 2001; 305: 181–6
   PubMed Web of Science ®Google Scholar
• Apple F. S., Wu A. H. B., Mair J., Ravkilde J., Panteghini M., et al. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin Chem 2005; 51: 810–24
   PubMed Web of Science ®Google Scholar